Seite 3 von 74
Neuester Beitrag: 23.05.20 18:07
|Eröffnet am:||18.05.10 21:18||von: Magnetfeldfr.||Anzahl Beiträge:||2.846|
|Neuester Beitrag:||23.05.20 18:07||von: Vassago||Leser gesamt:||310.419|
|Seite: < 1 | 2 | | 4 | 5 | 6 | 7 | 8 | 9 | ... 74 >|
Remember AQXP? (from 1 to 30),if there any bio(s) that could be compare with, is DCTH. they both been trading way under cash,both had a solid balance sheet and upcoming catalysts. and I did same risk/reward calculation:
after past week 10Q, Many have realized DCTH has legs.approved medical device in Europe!.
Right now is good time to buy imo when not many are talking about it yet and analysts are just starting to cover. When Institutions start buying it will explode and will be to late imo
aus dem ihub vom 11.11.2016:
DCTH price book is now $24 per share.share price $1.8,not for long imo. very impressive earnings and updates. just Beats(10Q) trading 1/10 cash+ restricted, a major world player for duct cancer,( p2/p3( deep in EU market (CE MARK), FDA approval, very limited share count ( 2.1M O/S) and $24 per share book value. $3.5m cap vs 200m-300m co if succeeded or bought out. Never saw so impressive risk/ reward ratio.